Jubilant Life gets USFDA nod for migraine treatment drug
The company has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (USFDA) for Rizatriptan Benzoate orally-disintegrating tablets, 5 mg and 10 mg, the company said in a BSE filing.